These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 33871391)

  • 1. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease.
    Lin BZ; Lin TJ; Lin CL; Liao LY; Chang TA; Lu BJ; Chen KY
    J Chin Med Assoc; 2021 Jun; 84(6):606-613. PubMed ID: 33871391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
    Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW
    Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
    Ahn SY; Kim SB; Song IH
    Can J Gastroenterol Hepatol; 2020; 2020():4873875. PubMed ID: 32566546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease.
    Tan YW; Wang JM; Zhou XB
    World J Hepatol; 2023 Feb; 15(2):237-254. PubMed ID: 36926239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence but decreased survival of nonviral hepatocellular carcinoma compared to viral hepatocellular carcinoma in recent ten years.
    Chen TC; Hsiao SW; Chen YY; Yen HH; Su WW; Hsu YC; Huang SP; Su PY
    Sci Rep; 2024 Apr; 14(1):9068. PubMed ID: 38643245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the relationship between nonalcoholic fatty liver disease and hepatocellular carcinoma in patients with prior hepatitis B virus infection].
    Chen L; Wang KF; Zhao Z; You QH; Wu YY; Sun J
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):52-56. PubMed ID: 35152669
    [No Abstract]   [Full Text] [Related]  

  • 7. Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes.
    Yen YH; Kuo FY; Eng HL; Liu YW; Yong CC; Wang CC; Li WF; Lin CY
    Updates Surg; 2024 Jun; 76(3):879-887. PubMed ID: 38582796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection.
    Lee J; Chang JI; Jin YJ; Lee JH; Kim JY; Sinn DH; Kim SS; Lee HW; Yoo SH; Yu JH; Lee JW
    Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):431-439. PubMed ID: 36728881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.
    Cho EJ; Kwack MS; Jang ES; You SJ; Lee JH; Kim YJ; Yoon JH; Lee HS
    Digestion; 2011; 84 Suppl 1():17-22. PubMed ID: 22156481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC.
    Yang T; Hu LY; Li ZL; Liu K; Wu H; Xing H; Lau WY; Pawlik TM; Zeng YY; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Li C; Wang MD; Wu MC; Shen F
    J Gastrointest Surg; 2020 Feb; 24(2):320-329. PubMed ID: 30617773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B-related hepatocellular carcinoma.
    Yoon JS; Lee HY; Chung SW; Kim SW; Chang Y; Lee YB; Cho EJ; Lee JH; Yu SJ; Kim H; Yoon JH; Kim YJ
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1960-1968. PubMed ID: 32128882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma.
    Benhammou JN; Aby ES; Shirvanian G; Manansala K; Hussain SK; Tong MJ
    Sci Rep; 2020 Jun; 10(1):9902. PubMed ID: 32555268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Analysis of Nonalcoholic Steatohepatitis- Versus Viral Hepatitis- and Alcohol-Related Liver Disease-Related Hepatocellular Carcinoma.
    Hester CA; Rich NE; Singal AG; Yopp AC
    J Natl Compr Canc Netw; 2019 Apr; 17(4):322-329. PubMed ID: 30959469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
    Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.
    Younossi ZM; Otgonsuren M; Henry L; Venkatesan C; Mishra A; Erario M; Hunt S
    Hepatology; 2015 Dec; 62(6):1723-30. PubMed ID: 26274335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
    Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features of non-alcoholic fatty liver disease in cryptogenic hepatocellular carcinoma].
    Rim MY; Kwon OS; Ha M; Kim JS; Ko KI; Kim DK; Jang PK; Han JY; Park PH; Jung YK; Choi DJ; Kim YS; Kim JH
    Korean J Gastroenterol; 2014 May; 63(5):292-8. PubMed ID: 24870301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term surgical outcomes of Non alcoholic fatty liver disease associated hepatocellular carcinoma.
    D'Silva M; Cho JY; Han HS; Yoon YS; Lee HW; Lee JS; Lee B; Kim M
    Surg Oncol; 2022 May; 41():101730. PubMed ID: 35231745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease-associated hepatocellular carcinoma in a hepatitis B virus-endemic area.
    Yoon CH; Jin YJ; Lee JW
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1090-1096. PubMed ID: 29847489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.